Memantine and prevention of worsening in functional communication: post hoc analysis of a randomized, placebo-controlled trial in patients with moderate Alzheimer's disease

被引：0
|
作者：
Graham, S. M. [1 ]
Tocco, M. [1 ]
Hendrix, S. [2 ]
Hofbauer, R. K. [1 ]
Perhach, J. L. [1 ]
机构：
[1] Forest Res Inst, Jersey City, NJ USA
[2] Pentara Corp, Salt Lake City, UT USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：355 / 355
页数：1
相关论文
共 50 条
  • [21] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: A Pooled Analysis
    Saxton, Judith
    Tocco, Michael
    Hofbauer, Robert K.
    Graham, Stephen M.
    NEUROLOGY, 2009, 72 (11) : A298 - A298
  • [22] Effects of Memantine on Language and Functional Communication in Patients with Moderate to Severe Alzheimer's Disease: a Pooled Analysis
    Saxton, J.
    Tocco, M.
    Hofbauer, R. K.
    Graham, S. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S170 - S170
  • [23] Effects of memantine on language and functional communication in patients with moderate to severe Alzheimer's disease
    Tocco, M.
    Graham, S. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S559 - S559
  • [24] A placebo-controlled study of memantine in advanced Alzheimer's disease.
    Reisberg, B
    Stoeffler, A
    Ferris, S
    Schmitt, F
    Doody, R
    Moebuis, HJ
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 90 - 90
  • [25] A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis
    De Carvalho, Mamede
    Pinto, Susana
    Costa, Joao
    Evangelista, Teresinha
    Ohana, Bemjamim
    Pinto, Anabela
    AMYOTROPHIC LATERAL SCLEROSIS, 2010, 11 (05): : 456 - 460
  • [26] Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease:: a double blind, randomized and placebo-controlled trial
    Akhondzadeh, S
    Noroozian, M
    Mohammadi, M
    Ohadinia, S
    Jamshidi, AH
    Khani, M
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (01) : 53 - 59
  • [27] Benefits of Extended-Release Memantine in Moderate-to-Severe Alzheimer's Disease as a Function of Disease Severity: Post Hoc Analysis from a Randomized Trial
    Tocco, Michael
    Hendrix, Suzanne
    Miller, Michael L.
    Pejovio, Vojislav
    Graham, Stephen M.
    ANNALS OF NEUROLOGY, 2013, 74 : S92 - S93
  • [28] Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors
    Grossberg, George T.
    Alva, Gustavo
    Hendrix, Suzanne
    Ellison, Noel
    Kane, Mary C.
    Edwards, John
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2018, 32 (03): : 173 - 178
  • [29] Memantine prevents worsening of communication abilities in patients with moderate to severe Alzheimer's disease: Mean change- and responder analysis
    Tariot, P. N.
    Saxton, J.
    Tocco, M.
    Hofbauer, R. K.
    Resnick, M.
    Graham, S. M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S104 - S104
  • [30] Memantine ER and Donepezil Treatment Maintains Cognitive Improvements Versus Donepezil Monotherapy: Post Hoc Analyses From a Placebo-controlled Study in Patients with Moderate-to-Severe Alzheimer's Disease
    Atri, Alireza
    Cummings, Jeffrey L.
    Hendrix, Suzanne
    Ellison, Noel
    Edwards, John
    NEUROLOGY, 2018, 90
12345